Company Profiles

driven by the PitchBook Platform

Adimab

Description

Producer of yeast-based therapeutic human antibodies designed to offer unprecedented quality and speed from target to therapeutic lead. The company's therapeutic human antibodies involves in the discovery, maturation and production of yeast-based immunoglobulin, enabling healthcare professionals to treat cancer as well as autoimmune and infectious diseases.

2007

Founded

PRIVATE

Status

51-200

Employees

Series F

Latest Deal Type

$13.8M

Latest Deal Amount

$42.6M

Total Amount Raised

Description

Producer of yeast-based therapeutic human antibodies designed to offer unprecedented quality and speed from target to therapeutic lead. The company's therapeutic human antibodies involves in the discovery, maturation and production of yeast-based immunoglobulin, enabling healthcare professionals to treat cancer as well as autoimmune and infectious diseases.

Website:

www.adimab.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

7 Lucent Drive Lebanon, NH 03766United States +1 (603) 643-7110
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Adimab's full profile, request a free trial.

Adimab Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Adimab Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Adimab Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Borealis VenturesVenture CapitalMinority000 0000000 0000
Georges HarikAngel (individual)Minority000 0000000 0000
GVCorporate Venture CapitalMinority000 0000000 0000
Mithril Capital ManagementVenture CapitalMinority000 0000000 0000
OrbiMedVenture CapitalMinority000 0000000 0000
Borealis Ventures Venture Capital
Georges Harik Angel (individual)
GV Corporate Venture Capital
Mithril Capital Management Venture Capital
OrbiMed Venture Capital

Adimab Executive Team (11)

NameTitleBoard
Seat
Contact
Info
Kirt JohnsonAssociate Director of Product Engineering
Kristin RookeyDirector, Alliance Management and Business Development
Anthony Cooper Ph.DResearch Scientist
Mary SchiavoniHead, Human Resources
Karl Wittrup Ph.DCo-Founder, Office of the CSO, Chairman of the SAB
Kirt Johnson Associate Director of Product Engineering
Kristin Rookey Director, Alliance Management and Business Development
Anthony Cooper Ph.D Research Scientist
Mary Schiavoni Head, Human Resources
Karl Wittrup Ph.D Co-Founder, Office of the CSO, Chairman of the SAB

Adimab Board Members (9)

NameRepresentingRoleSinceContact
Info
Ajay RoyanMithril Capital ManagementCo-Founder & Managing General Partner000 0000
Bill MarisGVFounder, Chief Executive Officerand, President & Managing Partner000 0000
Carl Gordon Ph.DOrbiMedFounding Partner & Co-Head of Global Private Equity000 0000
Errik AndersonSelfCo-Founder000 0000
Karl Wittrup Ph.DAdimabCo-Founder, Office of the CSO, Chairman of the SAB000 0000
Ajay Royan Co-Founder & Managing General Partner Mithril Capital Management
Bill Maris Founder, Chief Executive Officerand, President & Managing Partner GV
Carl Gordon Ph.D Founding Partner & Co-Head of Global Private Equity OrbiMed
Errik Anderson Co-Founder Self
Karl Wittrup Ph.D Co-Founder, Office of the CSO, Chairman of the SAB Adimab
Request full access to PitchBook